Oregon 2022 Regular Session Status: In Committee Bipartisan · 1 R · 1 D cosponsors

HB 4025 — Relating to pseudoephedrine; prescribing an effective date.

Last action — In committee upon adjournment.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Allows pharmacy intern to transfer drug containing pseudoephedrine subject to requirements that apply to transfer by pharmacist and pharmacy technician. Becomes operative January 1, 2023. Takes effect on 91st day following adjournment sine die.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 4025 on the official Oregon source →

Action History

  1. In committee upon adjournment.

  2. Referred to Health Care.

  3. First reading. Referred to Speaker's desk.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 1 co-sponsors · 86 not signed on

Sponsors (3)

Co-sponsors (1)

Not signed on (86)

86 members have not signed on to this bill.

Show all 86 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 4025 do?
Allows pharmacy intern to transfer drug containing pseudoephedrine subject to requirements that apply to transfer by pharmacist and pharmacy technician. Becomes operative January 1, 2023. Takes effect on 91st day following adjournment sine die.
Who sponsors HB 4025?
HB 4025 is sponsored by Deb Patterson (Democrat), Cedric Hayden (Republican), Jessica George, and Rachel Prusak.
What is the current status of HB 4025?
This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 4025?
Track HB 4025 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 4025

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 4025

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →